Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2015 Dec 21;151(5):1380–1388. doi: 10.1016/j.jtcvs.2015.12.028

Figure 2.

Figure 2

Overall Survival of Patients with Unsuspected pN2 Disease Stratified by Type of Adjuvant Therapy. Patients with “unsuspected N2” disease had underwent lobectomy as primary therapy for cT1-3 N0-1 NSCLC and were found to have pN2 disease at the time of surgery. These patients then went on to receive either adjuvant chemotherapy, adjuvant chemoradiation, adjuvant radiation therapy, or no adjuvant therapy.